Gene · 1612
Papers4,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37658212 | PubTator, text mining | PubMed |
| Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an in-silico approach towards therapeutic intervention. | J Biomol Struct Dyn | 2024 | 37387600 | PubTator, text mining | PubMed |
| Unveiling the Mechanisms of Bone Marrow Toxicity Induced by Lead Acetate Exposure. | Biol Trace Elem Res | 2024 | 37378799 | PubTator, text mining | PubMed |
| Structure-Based Virtual Screening and Discovery of New Bi-functional DAPK1 Inhibitors. | Mol Biotechnol | 2024 | 37351834 | PubTator, text mining | PubMed |
| Adenosine signaling inhibits erythropoiesis and promotes myeloid differentiation. | Haematologica | 2024 | 37199120 | PubTator, text mining | PubMed |
| Knockdown of DAPK1 inhibits IL-1β-induced inflammation and cartilage degradation in human chondrocytes by modulating the PEDF-mediated NF-κB and NLRP3 inflammasome pathway. | Innate Immun | 2024 | 36412004 | PubTator, text mining | PubMed |
Trimetazidine May Potentially Confer Neuroprotective Effects against COVID-19-Induced Neurological Sequelae via Inhibition of Death-Associated Protein Kinase 1 (DAPK1) Signaling Pathways: An Evidenced-Based Hypothesis. | Tanaffos | 2023 | 38628884 | PubTator, text mining | PubMed |
| A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma. | Front Oncol | 2023 | 38304027 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health. | Front Genet | 2023 | 38299096 | PubTator, text mining | PubMed |
| AEN Suppresses the Replication of Porcine Epidemic Diarrhea Virus by Inducing the Expression of Type I IFN and ISGs in MARC-145 Cells. | Pathogens | 2023 | 38251332 | PubTator, text mining | PubMed |
| Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women. | Vaccines (Basel) | 2023 | 38250859 | PubTator, text mining | PubMed |
| Autophagy-related mechanisms for treatment of multiple myeloma. | Cancer Drug Resist | 2023 | 38239705 | PubTator, text mining | PubMed |
| Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach. | Int J Mol Sci | 2023 | 38203429 | PubTator, text mining | PubMed |
| Promising and Minimally Invasive Biomarkers: Targeting Melanoma. | Cells | 2023 | 38201222 | PubTator, text mining | PubMed |
| Modulation of neural gene networks by estradiol in old rhesus macaque females. | bioRxiv | 2023 | 38187564 | PubTator, text mining | PubMed |
| JASPER: fast, powerful, multitrait association testing in structured samples gives insight on pleiotropy in gene expression. | bioRxiv | 2023 | 38187553 | PubTator, text mining | PubMed |
| Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers. | Front Immunol | 2023 | 38179042 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic strategies in ulcerative colitis. | Front Genet | 2023 | 38169708 | PubTator, text mining | PubMed |
| Identification of the role of autophagy-related TNFSF10/ hsa-let-7a-5p axis in vitiligo development and potential herbs exploring based on a bioinformatics analysis. | Heliyon | 2023 | 38149194 | PubTator, text mining | PubMed |
| An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38143910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1612/papers?page=10